C4 Therapeutics, Inc. Common Stock (CCCC)

Typically moves ±6.36% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-04 APPROXIMATE

C4 Therapeutics, Inc. Common Stock (CCCC) has reported earnings 21 times since May 13, 2021. The stock moves an average of ±6.36% the day after reporting, closing higher 66.7% of the time. Its largest post-earnings gain was +31.12% (Aug 07, 2025) and its largest decline was -13.91% (Nov 01, 2023). The next earnings report is predicted for 2026-08-04 (approximate).

Earnings reactions

How CCCC moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.36%

Positive %

66.7%

Negative %

33.3%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 12, 2026	☀ PRE	+0.16%	open_in_new
Feb 26, 2026	☀ PRE	+0.18%	open_in_new
Nov 06, 2025	☀ PRE	+0.42%	open_in_new
Aug 07, 2025	☀ PRE	+31.12%	open_in_new
May 07, 2025	☀ PRE	+6.79%	open_in_new
Feb 27, 2025	☀ PRE	-1.52%	open_in_new
Oct 31, 2024	☀ PRE	-3.79%	open_in_new
Aug 01, 2024	☀ PRE	-0.52%	open_in_new
May 08, 2024	☀ PRE	-5.15%	open_in_new
Feb 22, 2024	☀ PRE	+21.49%	open_in_new
Nov 01, 2023	☀ PRE	-13.91%	open_in_new
Aug 08, 2023	☀ PRE	+0.14%	open_in_new
May 04, 2023	☀ PRE	+3.19%	open_in_new
Feb 23, 2023	☀ PRE	+2.03%	open_in_new
Nov 03, 2022	☀ PRE	+1.96%	open_in_new
Aug 04, 2022	☀ PRE	+7.04%	open_in_new
May 05, 2022	☀ PRE	-3.93%	open_in_new
Feb 24, 2022	☀ PRE	+13.74%	open_in_new
Nov 10, 2021	☽ POST	-4.11%	open_in_new
Aug 11, 2021	☽ POST	+10.47%	open_in_new
May 13, 2021	☽ POST	+1.92%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.36%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 13 →

Funds holding

$47019423

Total value held

Buying

12 added · 1 reduced

Morgan Stanley

$23860411 +1.01%

Goldman Sachs Group Inc

$6278804 +119.22%

Bank Of America Corp /De/

$6204805 -1.19%

Blackrock, Inc.

$5387622 +4.00%

Wells Fargo & Company/Mn

$2282606 +7.25%

SEC Filing Types

description SCHEDULE 13G

2 chevron_right

description 144

1 chevron_right

description SCHEDULE 13G/A

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260713	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov

Frequently asked about CCCC earnings

When does C4 Therapeutics, Inc. Common Stock report earnings next? expand_more

C4 Therapeutics, Inc. Common Stock (CCCC)'s next earnings date is approximate for 2026-08-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CCCC stock move after earnings? expand_more

Over 21 reports, CCCC has moved an average of ±6.36% the session after earnings, closing higher 66.7% of the time.

What was CCCC's biggest post-earnings move? expand_more

CCCC's largest post-earnings gain on record was +31.12% on Aug 07, 2025, and its largest decline was -13.91% on Nov 01, 2023.

Where can I find C4 Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of C4 Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.